578 related articles for article (PubMed ID: 9408958)
41. Multidrug resistance-1 (MDR1) expression and functional dye/drug efflux is highly correlated with the t(8;21) chromosomal translocation in pediatric acute myeloid leukemia.
Pearson L; Leith CP; Duncan MH; Chen IM; McConnell T; Trinkaus K; Foucar K; Willman CL
Leukemia; 1996 Aug; 10(8):1274-82. PubMed ID: 8709631
[TBL] [Abstract][Full Text] [Related]
42. Expression of the human major vault protein LRP in acute myeloid leukemia.
Hart SM; Ganeshaguru K; Scheper RJ; Prentice HG; Hoffbrand AV; Mehta AB
Exp Hematol; 1997 Nov; 25(12):1227-32. PubMed ID: 9357965
[TBL] [Abstract][Full Text] [Related]
43. P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.
van der Kolk DM; de Vries EG; van Putten WJ; Verdonck LF; Ossenkoppele GJ; Verhoef GE; Vellenga E
Clin Cancer Res; 2000 Aug; 6(8):3205-14. PubMed ID: 10955805
[TBL] [Abstract][Full Text] [Related]
44. Molecular targets in oncology: implications of the multidrug resistance gene.
Lum BL; Gosland MP; Kaubisch S; Sikic BI
Pharmacotherapy; 1993; 13(2):88-109. PubMed ID: 8097038
[TBL] [Abstract][Full Text] [Related]
45. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.
Svirnovski AI; Shman TV; Serhiyenka TF; Savitski VP; Smolnikova VV; Fedasenka UU
Hematology; 2009 Aug; 14(4):204-12. PubMed ID: 19635183
[TBL] [Abstract][Full Text] [Related]
46. Identification of drug-resistant myeloid leukemic cells by measurement of DNA content, nuclear area, and detection of P-glycoprotein.
Emura I; Naito M; Kakihara T; Wakabayashi M; Hayashi N; Chou T
Cancer; 1996 Mar; 77(5):878-87. PubMed ID: 8608478
[TBL] [Abstract][Full Text] [Related]
47. Multidrug resistance as a potential prognostic indicator in acute myeloid leukemia with normal karyotypes.
Kim DH; Lee NY; Sung WJ; Baek JH; Kim JG; Sohn SK; Suh JS; Lee KS; Lee KB
Acta Haematol; 2005; 114(2):78-83. PubMed ID: 16103629
[TBL] [Abstract][Full Text] [Related]
48. Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia.
List AF
Leukemia; 1996 Jun; 10(6):937-42. PubMed ID: 8667648
[TBL] [Abstract][Full Text] [Related]
49. Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-beta-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia.
Schuurhuis GJ; Broxterman HJ; Ossenkoppele GJ; Baak JP; Eekman CA; Kuiper CM; Feller N; van Heijningen TH; Klumper E; Pieters R
Clin Cancer Res; 1995 Jan; 1(1):81-93. PubMed ID: 9815890
[TBL] [Abstract][Full Text] [Related]
50. P-glycoprotein and multidrug resistance-associated protein, but not lung resistance protein, lower the intracellular daunorubicin accumulation in acute myeloid leukaemic cells.
Borg AG; Burgess R; Green LM; Scheper RJ; Liu Yin JA
Br J Haematol; 2000 Jan; 108(1):48-54. PubMed ID: 10651723
[TBL] [Abstract][Full Text] [Related]
51. Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML.
Schoch C; Kern W; Schnittger S; Hiddemann W; Haferlach T
Leukemia; 2004 Jan; 18(1):120-5. PubMed ID: 14586477
[TBL] [Abstract][Full Text] [Related]
52. Relationship between MDR1 gene and surface markers in acute myeloid leukemia.
Zöchbauer S; Schwarzinger I; Strobl H; Lechner K; Pirker R
Anticancer Res; 1997; 17(1B):749-52. PubMed ID: 9066614
[TBL] [Abstract][Full Text] [Related]
53. P-glycoprotein (P-170) expression in acute leukemias.
Abd El-Ghaffar HA; Aladle DA; Farahat SE; Abd El-Hady N
Hematology; 2006 Feb; 11(1):35-41. PubMed ID: 16522547
[TBL] [Abstract][Full Text] [Related]
54. P-glycoprotein and multidrug resistance associated protein-1 activity in 132 acute myeloid leukemias according to FAB subtypes and cytogenetics risk groups.
Legrand O; Zompi S; Perrot JY; Faussat AM; Benderra Z; Chaoui D; Marie JP
Haematologica; 2004 Jan; 89(1):34-41. PubMed ID: 14754604
[TBL] [Abstract][Full Text] [Related]
55. Transport proteins in drug resistance: detection and prognostic significance in acute myeloid leukemia.
Broxterman HJ; Schuurhuis GJ
J Intern Med Suppl; 1997; 740():147-51. PubMed ID: 9350197
[TBL] [Abstract][Full Text] [Related]
56. P-glycoprotein in adult solid tumors. Expression and prognostic significance.
Leighton JC; Goldstein LJ
Hematol Oncol Clin North Am; 1995 Apr; 9(2):251-73. PubMed ID: 7642464
[TBL] [Abstract][Full Text] [Related]
57. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia.
Valera ET; Scrideli CA; Queiroz RG; Mori BM; Tone LG
Sao Paulo Med J; 2004 Jul; 122(4):166-71. PubMed ID: 15543372
[TBL] [Abstract][Full Text] [Related]
58. Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry.
Guerci A; Merlin JL; Missoum N; Feldmann L; Marchal S; Witz F; Rose C; Guerci O
Blood; 1995 Apr; 85(8):2147-53. PubMed ID: 7536492
[TBL] [Abstract][Full Text] [Related]
59. Impact of the expression of P glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat shock protein 27 on response to induction therapy and long-term survival in patients with de novo acute myeloid leukemia.
Kasimir-Bauer S; Beelen D; Flasshove M; Noppeney R; Seeber S; Scheulen ME
Exp Hematol; 2002 Nov; 30(11):1302-8. PubMed ID: 12423683
[TBL] [Abstract][Full Text] [Related]
60. Novel mechanisms of drug resistance in leukemia.
Ross DD
Leukemia; 2000 Mar; 14(3):467-73. PubMed ID: 10720143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
